Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model

Table 1 Effects of paclitaxel/NM-3 on the cell cycle progression (mean ± SD)

Group	G0/G1	S	G2/M
Control	24.13 ± 1.12	40.12 ± 1.09	32.17 ± 1.48
NM-3	34.42 ± 3.51	22.41 ± 2.13	18.23 ± 3.23
Paclitaxel	26.34 ± 0.35a	39.20 ± 0.39a	33.10 ± 0.89a
Paclitaxel/NM-3	87.42 ± 3.17b	9.12 ± 0.22b	15.12 ± 2.40b

^aP > 0.05 vs saline group;

^bP < 0.01 vs paclitaxel group).

Table 2 Effects of paclitaxel/NM-3 on the cell apoptosis (mean ± SD)

Group	AI
Control	13.24 ± 7.75
NM-3	25.62 ± 6.46a
Paclitaxel	28.90 ± 5.38a
Paclitaxel/NM-3	38.51 ± 5.14b

^aP < 0.05;

^bP < 0.01 vs control group.